TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
PROK

ProKidney Corp.

Healthcare · Biotechnology

1.60$ +1.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow PROK
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – -166,251.3% -13,451.0%
– – – – – 7,147.4% 736.3%
– – – – – 38,647.4% 2,837.2%
– – – – – 5,205.3% 143.4%
– – – – – 38,827.6% 1,701.7%
– – – – – 26,860.5% 11,642.2%
– – – – – 0.0% 0.0%
– – – – – -71.1% -2.9%
– – – – – 190,010.5% 2,863.3%
– – – – – 50,619.7% 1,054.5%
– – – – – -205,078.9% -15,152.6%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?